Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chromophobe renal cell carcinoma

Cancer Cell(2023)10.1016/j.ccell.2023.07.006Source: DataRank Database

Chromophobe renal cell carcinoma is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 0. It has been cited 51 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access51 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 8.62)OA: bronzeTopics (29)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Liang Cheng ORCID,A. Ari Hakimi ORCID,Toni K. Choueiri ORCID,David A. Braun ORCID,Elizabeth P. Henske ORCID

Live enrichment

PubMed:37541245 OpenAlex:https://openalex.org/W4385546110

Dana-Farber/Harvard Cancer Center

Grant: 2P50CA101942-16

Dana-Farber/Harvard Cancer Center

Grant: 5P30CA006516-56

U.S. Department of Defense

Grant: KCRP AKCI-ECI

U.S. Department of Defense

Grant: W81XWH-20-1-0882

Yale University Yale Cancer Center

Grant: P30CA016359

MSKCC

Grant: P30 CA008748

NCI NIH HHS

Grant: P30 CA006516

NCI NIH HHS

Grant: P50 CA101942

Harvard Medical School

National Institutes of Health

FWCI

8.62

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1535610823002465/pdf

publisherhttp://www.cell.com/article/S1535610823002465/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610823002465?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610823002465?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2023.07.006

Fields of Study

Renal cell carcinoma treatmentCancer Genomics and DiagnosticsFerroptosis and cancer prognosisHumansCarcinoma, Renal CellKidney NeoplasmsImmunity, InnateLymphocytesOxidative StressBiomarkers, Tumor

MeSH Terms

Carcinoma, Renal CellHumansImmunity, InnateKidney NeoplasmsLymphocytesBiomarkers, TumorOxidative Stress

Keywords

Clear cellBiologyCancer researchRenal cell carcinomaClear cell renal cell carcinomaChromophobe cellmTORC1PI3K/AKT/mTOR pathwayPathologySignal transductionMedicineCell biology

Sustainable Development Goals

SDG 0: Good health and well-being